Shockwave Medical, Inc
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$42.3M
Doctors Paid
12,945
Transactions
64,153
2024 Total
$10.8M
Payment Breakdown by Category
Research$21.5M (50.7%)
Consulting$4.3M (10.1%)
Food & Beverage$3.2M (7.6%)
Travel$827,037 (2.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $21.5M | 3,289 | 50.7% |
| Compensation for serving as faculty or as a speaker for a medical education program | $8.5M | 2,449 | 20.0% |
| Consulting Fee | $4.3M | 1,285 | 10.1% |
| Food and Beverage | $3.2M | 54,547 | 7.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.1M | 117 | 2.6% |
| Long term medical supply or device loan | $886,374 | 186 | 2.1% |
| Travel and Lodging | $827,037 | 1,783 | 2.0% |
| Acquisitions | $816,033 | 1 | 1.9% |
| Grant | $806,991 | 40 | 1.9% |
| Space rental or facility fees (teaching hospital only) | $328,918 | 27 | 0.8% |
| Education | $47,571 | 388 | 0.1% |
| Honoraria | $44,231 | 24 | 0.1% |
| Debt forgiveness | $7,107 | 2 | 0.0% |
| Gift | $116.48 | 14 | 0.0% |
| Current or prospective ownership or investment interest | $41.07 | 1 | 0.0% |
Payments by Type
Research
$21.5M
3,274 transactions
General
$20.8M
60,864 transactions
Ownership
$0
15 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| Disrupt PAD BTK II | $7.6M | 0 | 940 |
| Disrupt PAD III | $3.4M | 0 | 400 |
| Randomized study of the Shockwave Medical Peripheral Lithoplasty System used in combination with DCB versus standard balloon angioplasty used in combination with DCB to treat moderate and severely calcified femoropopliteal arteries (Disrupt PAD III) | $2.6M | 0 | 782 |
| Prospective, Multicenter, Single-Arm, Global IDE Study of the Shockwave Coronary Intravascular Lithotripsy (IVL) System with the Shockwave C2 Coronary IVL Catheter in Calcified Coronary Arteries (Disrupt CAD III Study), | $2.3M | 0 | 297 |
| EMPOWER CAD | $1.8M | 0 | 266 |
| Forward PAD | $1.1M | 0 | 207 |
| Disrupt CAD Duo | $851,435 | 0 | 114 |
| Disrupt CAD III | $393,447 | 0 | 185 |
| Disrupt PAD+ | $380,793 | 0 | 29 |
| PILOT study: AI-guided image analysis to quantify the mechanism and efficacy of IVL (OCT Mechanism) | $262,500 | 0 | 3 |
| OCT Deep Analysis | $226,994 | 0 | 4 |
| Cost Claims Retrospective Collection Study | $119,154 | 0 | 9 |
| CN Retrospective | $97,500 | 0 | 2 |
| OA vs IVL | $97,073 | 0 | 2 |
| Prospective, Multi-center, Single-arm Study of the Shockwave Medical M5+ Peripheral Intravascular Lithotripsy (IVL) System in Calcified Peripheral Arteries | $61,805 | 0 | 10 |
| CathPCI STEMI | $60,000 | 0 | 1 |
| Staged Pre-TAVR | $56,900 | 0 | 9 |
| Shockwave vs surgical endarterectomy of calcified severe common femoral artery stenosis (IVL v CFE) | $38,650 | 0 | 4 |
| BTK Recoil | $35,791 | 0 | 1 |
| A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) | $19,492 | 0 | 3 |
| TIARA-I | $11,935 | 0 | 1 |
| Shockwave Medical Intravascular Lithotripsy System Studies IVL.02.21 | $2,500 | 0 | 1 |
Payments by Medical Specialty
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Frederic Moll, M.d, M.D | General Practice | Redwood City, CA | $1.1M | $0 |
| Daniel Clair, Md, MD | Surgery | Nashville, TN | $838,874 | $0 |
| Dr. Todd Brinton, M.d, M.D | Cardiovascular Disease | Stanford, CA | $598,608 | $0 |
| Dr. Ziad Ali, Md Dphil, MD DPHIL | Internal Medicine | New York, NY | $480,526 | $0 |
| George Adams, M.d, M.D | Cardiovascular Disease | Garner, NC | $405,293 | $0 |
| Mazin Foteh, Md, MD | Vascular Surgery | Austin, TX | $369,130 | $0 |
| Dr. Vamsi Krishna, M.d, M.D | Interventional Cardiology | Kyle, TX | $341,237 | $0 |
| Dr. Sarang Mangalmurti, Md, MD | Cardiovascular Disease | Bryn Mawr, PA | $321,840 | $0 |
| Frank Arko, Md, MD | Cardiovascular Disease | Charlotte, NC | $317,924 | $0 |
| Dr. Robert Riley, M.d, M.D | Interventional Cardiology | Bellevue, WA | $240,821 | $0 |
| Sameh Sayfo | Internal Medicine | Plano, TX | $222,423 | $0 |
| Dr. Brian Jefferson, Md, MD | Internal Medicine | Nashville, TN | $219,115 | $0 |
| Dr. Gregg Stone, M.d, M.D | Cardiovascular Disease | New York, NY | $210,000 | $0 |
| Dr. John Lasala, Md, MD | Internal Medicine | Saint Louis, MO | $188,398 | $0 |
| Dr. Darshan Doshi, M.d, M.D | Internal Medicine | Boston, MA | $152,900 | $0 |
| John Corl, Md, MD | Cardiovascular Disease | Cincinnati, OH | $146,577 | $0 |
| Rhian Davies, D.o, D.O | Cardiovascular Disease | York, PA | $145,246 | $0 |
| Srinivasa Potluri, Md, MD | Cardiovascular Disease | Plano, TX | $140,447 | $0 |
| Christopher Brown, Md, MD | Interventional Cardiology | Seattle, WA | $140,012 | $0 |
| Leigh Ann O'banion, M.d, M.D | Surgery | Fresno, CA | $133,658 | $0 |
| Dr. Matthew Price, M.d, M.D | Interventional Cardiology | La Jolla, CA | $129,057 | $0 |
| Dr. Paul Teirstein, M.d, M.D | Cardiovascular Disease | La Jolla, CA | $128,881 | $0 |
| Mathew Wooster, M.d, M.D | Vascular Surgery | West Columbia, SC | $126,559 | $0 |
| Nicolas Mouawad | Student in an Organized Health Care Education/Training Program | West Branch, MI | $117,296 | $0 |
| Jeffrey Tyler, M.d, M.D | Interventional Cardiology | Orange, CA | $116,148 | $0 |
Ad
Top Products
- SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER $13.3M
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter $8.7M
Associated Products (19)
- SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER $13.3M
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter $8.7M
- Vascular Lithotripsy $4.2M
- Shockwave M5 $3.2M
- Shockwave Medical Peripheral Lithoplasty System $2.0M
- SHOCKWAVE S4 $1.6M
- SHOCKWAVE INTRAVASCULAR LITHOTRIPSY (IVL) SYSTEM WITH THE SHOCKWAVE M5+ $1.4M
- Javelin Peripheral IVL Catheter $998,126
- Shockwave Intravascular Lithotripsy (IVL) System with the Shockwave C2+ Coronary $866,707
- Shockwave S4 $565,739
- Shockwave Intravascular Lithotripsy (IVL) System with the Shockwave M5+ $340,768
- SHOCKWAVE M5 $106,282
- Shockwave Intravascular Lithotripsy (IVL) Generator and Connector Cable $93,653
- Intravascular Lithotripsy $90,068
- VASCULAR LITHOTRIPSY $83,494
- SHOCKWAVE INTRAVASCULAR LITHOTRIPSY (IVL) GENERATOR AND CONNECTOR CABLE $61,979
- Shockwave Medical L6 Intravascular Lithotripsy (IVL) Catheter $25,241
- SHOCKWAVE INTRAVASCULAR LITHOTRIPSY (IVL) SYSTEM WITH THE SHOCKWAVE C2+ CORONARY $17,683
- Shockwave Intravascular Lithotripsy (IVL) System with the Shockwave E8 Peripher $14,679
Payment Categories
- Food & Beverage $3.2M
- Consulting $4.3M
- Travel & Lodging $827,037
- Research $21.5M
About Shockwave Medical, Inc
Shockwave Medical, Inc has made $42.3M in payments to 12,945 healthcare providers, recorded across 64,153 transactions in the CMS Open Payments database. In 2024, the company paid $10.8M. The top product by payment volume is SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER ($13.3M).
Payments were distributed across 156 medical specialties. The top specialty by payment amount is Cardiovascular Disease ($6.1M to 3,054 doctors).
Payment categories include: Food & Beverage ($3.2M), Consulting ($4.3M), Research ($21.5M), Travel & Lodging ($827,037).
Shockwave Medical, Inc is associated with 19 products in the CMS Open Payments database, including SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER, Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter, and Vascular Lithotripsy.